Used in pharmaceutical research as a key intermediate in the synthesis of neuroactive compounds, particularly those targeting serotonin and dopamine receptors. Shows potential in the development of treatments for anxiety, depression, and other central nervous system disorders. Its structure supports enhanced blood-brain barrier penetration, making it valuable in optimizing bioavailability of psychoactive drugs. Also investigated for use in positron emission tomography (PET) tracer development due to its selective binding properties.